Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.25
Bid: 27.00
Ask: 27.50
Change: 3.00 (12.37%)
Spread: 0.50 (1.852%)
Open: 24.25
High: 28.50
Low: 26.00
Prev. Close: 24.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS: Sports Direct Expects Earnings To Beat Forecasts

Thu, 28th May 2015 10:35

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 WINNERS
-------
Sports Direct International, up 4.3%. The sporting goods retailer said it will provide an update on its outlook for the financial year to April 26 at its annual conference on Thursday, saying underlying earnings before interest, taxation, depreciation and amortisation will be in line with market expectations, while both underlying pretax profit and earnings per share are set to be ahead.

Kingfisher, up 3.4%. The DIY retailer reported a drop in total revenue in the first quarter of its financial year as it was hit by adverse currency movements, but said it is making good progress with its turnaround plans. The retailer reported total sales of GBP2.59 billion for the 13 weeks to May 2, which is a 4.6% decline on the same period the year before, but would have been an increase of 2.7% had exchange rates remained constant. The group's performance was boosted by a strong performance in the UK and Ireland where total sales grew 2.9%.

International Consolidated Airlines Group, up 1.5%. The company said its EUR2.55 per share offer for Irish flag carrier Aer Lingus Group is its final offer and will not be raised. Aer Lingus shares are flat at EUR2.44. Aer Lingus shareholder Ryanair is down 1.3% at EUR11.60.

Direct Line Insurance Group, up 1.3%. JP Morgan has upgraded the motor insurer to Overweight from Neutral.
-------
FTSE 100 LOSERS
-------
Intertek Group, down 1.6%. Deutsche Bank has downgraded the testing, certification and inspection services provider to Hold from Buy.

Marks & Spencer Group, down 1.3%, and Whitbread, down 0.8%. The companies have gone ex-dividend, meaning new buyers no longer qualify for the latest dividend payouts.

Glencore, down 1.2%. Private equity group First Reserve Corp is to sell the remaining part of its stake in mining and commodities company Glencore, Reuters reported.
-------
FTSE 250 WINNERS
-------
PayPoint, up 6.2%. The payments services company reported higher pretax profit in its last financial year, driven by growth in its retail networks, and hiked its dividend on the back of the results. It said it made a GBP49.6 million pretax profit in the year ended March 31, compared with GBP46.0 million in the prior year. Revenue increased by 3.0% to GBP218.5 million due to growth across its retail networks, with margins improving.

Infinis Energy, up 3.7%. The British renewable energy company said it swung to profit from a substantial loss in the last financial year leading the company to significantly raise its dividend, as expected, as the expansion of its wind farms continues to progress on schedule.

Zoopla Property Group, up 2.6%. Jefferies has raised its price target for the online property portal to 400.00 pence from 269.00p, reiterating its Buy rating. Zoopla currently trades at 246.20p.

Premier Oil, up 2.3%. The companies involved in the Isobel deep exploration well offshore the Falkland Islands said they have made an oil discovery that has similar properties to the discovery made at the Sea Lion project. Premier Oil is the operator of the well with 36% stake. Shares in partner Falkland Oil and Gas are down 3.4%, while those of third partner Rockhopper Exploration are up 7.7%.
-------
FTSE 250 LOSERS
-------
SOCO International, down 4.1%, AMEC Foster Wheeler, down 3.7%, Cable & Wireless Communications, down 2.3%, Spectris, down 1.9%, Premier Farnell, down 1.9%, Inchcape, down 1.3% and Marston's, down 1.3%. The companies have gone ex-dividend.

Tate & Lyle, down 3.3%. The sugar and sweeteners company reported a huge drop in profit in its recently-ended financial year after suffering from issues with its supply chain, a weak performance from its bulk ingredients business, and tough market conditions for its SPLENDA Sucralose product.

ICAP, down 2.3%. Numis has cut the inter-dealer broker to Sell from Hold.
-------
AIM ALL-SHARE WINNERS
-------
Connemara Mining Co, up 23%. The company said it has received encouraging initial results from the Inishowen gold licences in Donegal in Ireland. Connemara said the initial results indicate quartz vein boulders up to 45 centimetres in diameter containing robust gold grades. The gold grades obtained in the initial results range up to 15.35 grams per tonne, the company said.

Stellar Diamonds, up 12%. The company said it has almost reached USD1.0 million in sales during 2015 after completing another auction of diamonds from the Baoule project in Guinea. The company said it raised USD505,000 before costs in the latest auction which was held online and brought the total sales for the year to USD922,000, which has mainly come from diamonds extracted from Baoule.

Camco Clean Energy, up 12%. The clean energy and energy storage company said it has struck a deal to sell its US carbon credit portfolio for a total of USD2.24 million.
-------
AIM ALL-SHARE LOSERS
-------
Marimedia, off 38%. The online advertising technology company said it anticipates its 2015 results will be materially below market expectations owing to a decision by the company to exit the display advertising sector and focus solely on mobile.

Northbridge Industrial Services, down 25%. The company said it sees "no reliable signs of any upturn" in the oil and gas sector in 2015 and said it expects to make a loss in the first half as the company slashes jobs and expenditure whilst closing and selling some of its operations to mitigate the difficulties in the sector.

Sareum Holdings, down 22%. The company said it has raised GBP1.4 million in a discounted share placing. Sareum said it had raised the funding via the issue of 577.4 million shares at 0.25 pence per share. The net proceeds are to be used to back its drug development programmes and for working capital. Sareum currently trades at 0.2795p.

Belgravium Technologies, down 15%. The mobile computing services company said it has secured a recent order for mobile systems but said delays to the contract will hit its first-half results.

Gable Holdings, down 10%. The non-life insurer said it swung to a loss in 2014 as it provided additional reserves to reduce a gap between the reserves it carries and the actuarial best estimate. Gable's pretax loss amounted to GBP5.4 million in 2014, a significant reversal from the GBP7.2 million pretax profit reported for the prior year.
-------
By Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
7 Dec 2023 14:31

UK shareholder meetings calendar - next 7 days

Friday 8 December 
Amedeo Air Four Plus LtdAGM
Ashoka India Equity Investment Trust PLCAGM
Associated British Engineering PLCAGM
Associated British Foods PLCAGM
Corcel PLCGM re disposal of 41% interest in the Mambare nickel/cobalt project
Hargreaves Lansdown PLCAGM
URA Holdings PLCGM re closing the fundraise
Monday 11 December 
IamFire PLCAGM with vote on name change to WeCap PLC
Pharma C Investments PLCGM re allowing investments in fintech, AI sectors
SigmaRoc PLCGM re reverse takeover
Tribal Group PLCGM re cash offer by Tiger Bidco 1 Ltd
Vela Technologies PLCAGM
Tuesday 12 December 
Atalaya Mining PLCEGM re redomiciliation to Spain from Cyprus
Blackrock Greater Europe Investment Trust PLCAGM
Distil PLCGM re placing and subscription
Gelion PLCAGM
Wednesday 13 December 
Dechra Pharmaceuticals PLCAGM
Limitless Earth PLCAGM
Softcat PLCAGM
Volution Group PLCAGM
Thursday 14 December 
Aeorema Communications PLCAGM
CleanTech Lithium PLCGM re equity raise approval
Driver Group PLCFull Year Results
eEnergy Group PLCAGM
Ethernity Networks LtdGM re authority to allot shares on non-preemptive basis
Fintech Asia LtdAGM
Helium One Global LtdAGM
Marwyn Value Investors LtdAGM
Quarto Group IncGM re cancelling trading on London's Main Market
Sareum Holdings PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
23 Nov 2023 14:28

IN BRIEF: Sareum Holdings draws down on equity prepayment facility

Sareum Holdings PLC - Cambridge, England-based pharmaceutical company, focused on developing kinase inhibitors to treat autoimmune diseases and cancer - Says that it has drawn down on the GBP300,000 second deposit in respect of a previously announced equity prepayment facility.

Read more
9 Nov 2023 13:47

EARNINGS AND TRADING: MetalNRG hails Gold Ridge findings

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
3 Nov 2023 13:59

Sareum secures Japan patent for kinase inhibitor asset

(Sharecast News) - Biotechnology firm Sareum announced on Friday that it has received a notice of allowance from the Japan Patent Office for a patent associated with SDC-1801, its primary TYK2/JAK1 kinase inhibitor.

Read more
3 Nov 2023 09:01

Sareum says patent notice in Japan boosts confidence in SDC-1801

(Alliance News) - Sareum Holdings PLC on Friday said it received a notice of allowance from Japan's Patent Office for a patent relating to its lead TYK2/JAK1 kinase inhibitor, SDC-1801.

Read more
9 Oct 2023 15:06

Sareum losses widen as clinical trials continue

(Sharecast News) - Biotechnology company Sareum Holdings reported a loss of £3.2m after tax in its final results on Monday, widening from last year's £2.2m due to heightened expenses from initiating clinical studies with SDC-1801, despite aligning with market anticipations.

Read more
9 Oct 2023 10:58

Sareum says earnings down but product development going well

(Alliance News) - Sareum Holdings PLC on Monday said its annual loss widened and its cash reserves are substantially reduced, but that development and testing of its medicinal products is progressing well.

Read more
6 Sep 2023 14:35

Director dealings: Blackbird, Sareum insiders pick up shares

(Sharecast News) - Blackbird found itself with a number of entries on the list of director buys on Wednesday, after a number of insiders and associates bought shares.

Read more
4 Sep 2023 09:18

Sareum begins dosing participants in phase 1a trial for SDC-1801

(Alliance News) - Sareum Holdings PLC on Monday said it has successfully started the multiple ascending dose part of its phase 1a clinical trial for its SDC-1801 drug, following approval from the safety review committee.

Read more
16 Aug 2023 13:13

Sareum flagship drug trial progressing well ahead of annual results

(Alliance News) - Sareum Holdings PLC on Wednesday said a clinical trial for its main therapeutic is continuing as planned, and it hopes to use a new prepayment facility to further enhance development.

Read more
3 Aug 2023 14:16

IN BRIEF: Sareum secures GBP5 million of funding from RiverFort Global

Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune diseases and cancers - Agrees terms on equity prepayment facility of up to GBP5 million with RiverFort Global Opportunities PCC Ltd, as arranged by RiverFort Global Capital Ltd, with an initial deposit of GBP2 million. This is expected on August 4, net of associated costs.

Read more
26 Jun 2023 17:33

TRADING UPDATES: New patents for Sareum; Guanajuato hails assessment

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Monday and not separately reported by Alliance News:

Read more
26 Jun 2023 10:54

Sareum granted new patents in China, US

(Sharecast News) - Clinical-stage biotechnology developer Sareum announced the granting of patents for its lead kinase inhibitors in China and the United States on Monday.

Read more
6 Jun 2023 13:36

IN BRIEF: Sareum doses first subjects in psoriasis drug trial

Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune diseases and cancers - Announces successful dosing of first test subjects in a randomised, placebo-controlled phase 1a clinical trial for lead programme SDC-1801. SDC-1801 is a dual TYK2/JAK1 kinase inhibitor and potential new therapeutic for various autoimmune diseases with an initial focus on psoriasis. The phase 1a trial will investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of SDC-1801 in healthy subjects, in single and multiple ascending oral dose studies. Dosing has started in a specialist clinical unit in Melbourne, Australia. Sareum expects full safety data to become available during the first half of 2024, after which a phase 1b clinical study will commence post-haste if the Phase 1a trial obtains satisfactory results.

Read more
18 May 2023 14:31

TRADING UPDATES: Nuformix says NXP002 shows anti-inflammatory effect

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.